Leslie E Stolz Selected Research

ecallantide

3/2015	Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.
4/2014	Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.
8/2013	Use of ecallantide in pediatric hereditary angioedema.
3/2013	Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
3/2013	Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.
3/2012	Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.
1/2012	Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leslie E Stolz Research Topics

Disease

7	Hereditary Angioedemas 03/2015 - 01/2012
2	Pain (Aches) 04/2014 - 03/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 03/2015
1	Hypersensitivity (Allergy) 03/2015
1	Immediate Hypersensitivity 03/2015
1	Anaphylaxis (Anaphylactic Shock) 03/2015
1	Hypertrophy 06/2004

Drug/Important Bio-Agent (IBA)

7	ecallantide FDA Link 03/2015 - 01/2012
2	Plasma KallikreinIBA 03/2015 - 10/2014
1	LDL CholesterolIBA 01/2021
1	NucleotidesIBA 01/2021
1	Pharmaceutical PreparationsIBA 03/2015
1	Immunoglobulin E (IgE)IBA 03/2015
1	lanadelumabIBA 10/2014
1	Monoclonal AntibodiesIBA 10/2014
1	Biological ProductsIBA 10/2014
1	BradykininIBA 03/2012
1	MyostatinIBA 06/2004